Position
Fidelity in Immuneering Corp
Back to the book · All holders of IMRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$2.72M$5.27 → $4.99
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 9.69M | $63.7M | — | — | — | 0.0% |
| Q1 2026 | 9.7M | $51.1M | $5.27 | −$12.7M | $65.6K | 0.0% |
| Q2 2026 | 9.7M | $48.4M | $4.99 | −$2.72M | $33.3K | 0.0% |